Clinical Trials Logo
  1. Home
  2. Other
  3. NCT04090684

Ciprofloxacin/Celecoxib Combination in Patients With ALS

ALS (Amyotrophic Lateral Sclerosis) Clinical Trial

Official title:
Open Label, Off Label Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of Ciprofloxacin/Celecoxib Combination in Patients With ALS

Clinical Trial Summary

This is an open label, off label study, to provide interested ALS patients with Ciprofloxacin/Celecoxib fixed dose combination, while assessing safety and tolerability, routine disease progression measures (ALSFRS-R and Vital Capacity).

Clinical Trial Description

Patients will be prescribed a fixed dose combination of Ciprofloxacin and Celecoxib to be taken twice daily, and will be monitored for safety and tolerability. Additionally, routine progression measures will be assessed. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT04090684
Study type Interventional
Source NeuroSense Therapeutics Ltd.
Contact
Status Completed
Phase Phase 1
Start date December 9, 2019
Completion date January 20, 2022
View Details
See also
  Status Clinical Trial Phase
Terminated NCT02528071 - Prognostic Value of a Diaphragmatic Endurance Test in Patients With Amyotrophic Lateral Sclerosis
Active, not recruiting NCT03604822 - Music Therapy Protocol to Support Bulbar and Respiratory Functions in ALS N/A
Completed NCT02891629 - Safety and Feasibility of the EyeControl Device N/A
Completed NCT02164253 - Focal Accumulation of Iron in Cerebral Regions in Early ALS (Amyotrophic Lateral Sclerosis) Patients Phase 2
Completed NCT00786032 - A Clinical Demonstration of EEG Brain-computer Interface for ALS Patients N/A
Recruiting NCT03787420 - Development and Needs Assessment and Efficiency of Smart Communication System for Patients With ALS. N/A
Recruiting NCT05663008 - Impairments of Neuro-muscular Communication in Motor-Neuron Disease: A Bio-Marker for Early and Personalised Diagnosis
Active, not recruiting NCT02286011 - Intramuscular Infusion of Autologous Bone Marrow Stem Cells in Patients With Amyotrophic Lateral Sclerosis Phase 1
Recruiting NCT03330353 - Chromatic Pupillometry to Assess the Melanopsin-Light Pathway in Progressive Supranuclear Palsy N/A
Active, not recruiting NCT03081338 - A Programme for Amyotrophic Lateral Sclerosis Care in Europe N/A
Active, not recruiting NCT03241784 - T-Regulatory Cells in Amyotrophic Lateral Sclerosis Phase 1
Not yet recruiting NCT04849065 - Clinical Trial on the Use of Cell Therapy in the Treatment of Patients With Amyotrophic Lateral Sclerosis Phase 2
Active, not recruiting NCT05276349 - Home-based Remote Digital Monitoring to Assess ALS Progression (Track ALS)
Active, not recruiting NCT04055623 - T-regulatory Cells in ALS Phase 2
Completed NCT02709330 - ALS Reversals - Lunasin Regimen Phase 2
Completed NCT03482050 - A Study to Evaluate Transplantation of Astrocytes Derived From Human Embryonic Stem Cells, in Patients With Amyotrophic Lateral Sclerosis (ALS) Phase 1/Phase 2